Comparison of the glycemic variability metrics values calculated using FGM vs. CGM sensor glucose measured simultaneously

Not Applicable

• Conditions: type 2 diabetes

• Registration Number: JPRN-UMIN000033431
• Lead Sponsor: Inuyama Chuo General Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-07-18
• Study Completion: 2020-09-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Not provided

Exclusion Criteria

Judged to be unsuitable for participation for medical reasons

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The formulae which predict the following glycemic variability metrics values calculated using CGM sensor glucose (every 5 minutes [iPro2]) from those calculated using FGM sensor glucose (every 15 minutes [FreeStyle Libre Pro]). (if significant association exists) Percentage of time in target range (70~180 mg/dL) Mean absolute glucose (MAG) Glycemic variability percentage (GVP) Mean glucose level Standard deviation (SD) Coefficient of variation (CV) Low blood glucose index (LBGI) High blood glucose index (LBGI)

Secondary Outcome Measures

Name	Time	Method
The association between glycemic variability metrics values (every 5 minutes [iPro2], 15 (extraction) minutes [iPro2], and 15 minutes [FreeStyle Libre Pro]) (except primary endpoint)